It should not be a great surprise to any of us, but a recently published study in the August issue of Archives of Internal Medicine concluded that there are significant gaps between what doctors think their patients know and what patients say they know! The study consisted of a survey of 89 patients and 43 [...]
The Center for Medicare and Medicaid Services (CMS), the U.S. agency in charge of Medicare, announced yesterday that it has scheduled a meeting to discuss the coverage of Dendreon’s prostate cancer vaccine Provenge. The meeting has been scheduled for this November 17. […]
The Patient Advocate Foundation (PAF), a national non-profit has announced that it has received a substantial contribution which will provide additional funding support for prostate cancer patients through its Co-Pay Relief Program (CPR). […]
When you are diagnosed with cancer one of the hurdles you might face is a financial one. Bills can accumulate quickly so it might be a good idea to seek financial help early on after being diagnosed. […]
A member of the advanced prostate cancer on-line support group who is the wife of an advanced prostate cancer survivor in New Mexico just informed us that Trailblazer (the MAC that controls New Mexico reimbursements for Medicare and Medicaid) has said they will not pay for her husband to get Provenge. They were also told [...]